CHLORINATED PARRAFINS INDUSTRY ASSOCIATION (EIN 521534760) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1987

Legal Domicile

Principal Officer

Andrew Jaques

Phone

3014619695

Tax Period

2025-01-01 to 2025-12-31

CHLORINATED PARRAFINS INDUSTRY ASSOCIATION, founded in 1987, is a small nonprofit that reported $137K in total revenue in fiscal year 2025. Revenue surged 31% from the prior year, signaling strong growth momentum. Expenses of $486K exceeded revenue, resulting in a 254% operating deficit.

Mission

TO ADDRESS THE SCIENTIFIC, REGULATORY & RELATED ISSUES WHICH MAY IMPACT HEALTH, SAFETY & ENVIRONMENTAL ASPECTS OF THE MANUFACTURE, STORAGE, DISTRIBUTION AND USE OF CHLORINATED PARRAFINS AND RELATED CHEMICALS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $132,020

Investment Income $5,445

Other Revenue $0

TOTAL REVENUE $137,465

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Other Expenses $486,298

TOTAL EXPENSES $486,298

Year-over-Year Comparison

	2025	2024	Change
Revenue	$137,465	$105,173	+0.3%
Expenses	$486,298	$330,673	+0.5%
Net Income	$-348,833	$-225,500	+0.5%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Damon Stevenson	DIRPRES Dover Chem EMPLOYEE	1.00	Officer Director	$0	$0	$0
Stephanie Epply	DIRECTORVP INOVYN EMPLOYEE	1.00	Officer Director	$0	$0	$0
Andrew Jaques	Executive Dir 4CL-EMPLOYEE	15.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$137,465	$486,298	$232,372	$-348,833
2024	No data	No data	No data	No data
2023	$835,399	$228,533	$821,027	$606,866
2022	$273,301	$252,618	$195,764	$20,683
2021	$216,190	$208,496	$177,448	$7,694
2020	$203,927	$288,980	$213,517	$-85,053
2019	$195,009	$424,269	$394,006	$-229,260
2018	$327,702	$232,554	$591,291	$95,148

CHLORINATED PARRAFINS INDUSTRY ASSOCIATION